Literature DB >> 31889547

Human papilloma virus related squamous cell carcinomas of the head and neck: diagnosis, clinical implications and detection of HPV.

Elizabeth C Paver1, Alexandra M Currie1, Ruta Gupta2, Jane E Dahlstrom3.   

Abstract

High-risk human papillomavirus (HPV) positive squamous cell carcinoma (SCC) of the head and neck is reported most commonly in the oropharynx but can also uncommonly be found in other sites such as the anterior oral cavity and sinonasal tract. While HPV positive oropharyngeal squamous cell carcinoma (HPV-OPSCC) has been shown to have a more favourable prognosis than conventional smoking- and alcohol-related anterior oral cavity squamous cell carcinoma (OSCC), HPV positive SCC arising elsewhere in the head and neck region does not carry the same favourable prognosis. HPV-OPSCC often tends to present with large cystic metastases in the cervical lymph nodes, with a clinically and radiologically occult primary. Correct diagnosis of the initial biopsy/cytology specimen is critical for directing further investigations and management. In recognition of its distinct biological behaviour, the 8th edition of the American Joint Commission on Cancer (AJCC 8) has proposed a separate clinical and pathological staging system for HPV-OPSCC compared to that for a conventional primary OSCC or neck metastasis of similar size. The new AJCC staging does not apply to other HPV positive SCC of the head and neck. This review examines the current biology of HPV positive SCC, focusing on HPV-OPSCC. The value and pitfalls of current detection methods of HPV are discussed with an emphasis on the role of the pathologist in the diagnosis and management of HPV positive SCC of the head and neck.
Copyright © 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HPV; Head and neck; human papilloma virus; in situ hybridisation; molecular; oral cavity; oropharyngeal squamous cell carcinoma; p16; sinonasal tract

Mesh:

Year:  2019        PMID: 31889547     DOI: 10.1016/j.pathol.2019.10.008

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  19 in total

1.  EZH2 regulates a SETDB1/ΔNp63α axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma.

Authors:  Seamus Balinth; Matthew L Fisher; Yon Hwangbo; Caizhi Wu; Carlos Ballon; Xueqin Sun; Alea A Mills
Journal:  Oncogene       Date:  2022-07-21       Impact factor: 8.756

2.  Detection of Human Papillomavirus in Squamous Lesions of the Conjunctiva Using RNA and DNA In-Situ Hybridization.

Authors:  Cornelia Peterson; Rupin N Parikh; Meleha T Ahmad; Ashley A Campbell; Yassine Daoud; Nicholas Mahoney; Sepideh Siadati; Charles G Eberhart
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

Review 3.  Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches.

Authors:  Giacomo Miserocchi; Chiara Spadazzi; Sebastiano Calpona; Francesco De Rosa; Alice Usai; Alessandro De Vita; Chiara Liverani; Claudia Cocchi; Silvia Vanni; Chiara Calabrese; Massimo Bassi; Giovanni De Luca; Giuseppe Meccariello; Toni Ibrahim; Marco Schiavone; Laura Mercatali
Journal:  J Pers Med       Date:  2022-05-24

4.  Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas.

Authors:  Giacomo Miserocchi; Claudia Cocchi; Alessandro De Vita; Chiara Liverani; Chiara Spadazzi; Sebastiano Calpona; Giandomenico Di Menna; Massimo Bassi; Giuseppe Meccariello; Giovanni De Luca; Angelo Campobassi; Maria Maddalena Tumedei; Alberto Bongiovanni; Valentina Fausti; Franco Cotelli; Toni Ibrahim; Laura Mercatali
Journal:  Cancer Biol Med       Date:  2021-03-27       Impact factor: 4.248

Review 5.  Importance of investigating high-risk human papillomavirus in lymph node metastasis of esophageal adenocarcinoma.

Authors:  Preeti Sharma; Shweta Dutta Gautam; Shanmugarajah Rajendra
Journal:  World J Gastroenterol       Date:  2020-06-07       Impact factor: 5.742

6.  PSMC2, ORC5 and KRTDAP are specific biomarkers for HPV-negative head and neck squamous cell carcinoma.

Authors:  Yushen Su; Zhirui Zeng; Dongyun Rong; Yushi Yang; Bei Wu; Yu Cao
Journal:  Oncol Lett       Date:  2021-02-12       Impact factor: 2.967

Review 7.  The Dark Side of the Force: When the Immune System Is the Fuel of Tumor Onset.

Authors:  Elisabeth Digifico; Silvia Balinzo; Cristina Belgiovine
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

8.  High Expression of Tomm34 and Its Correlations With Clinicopathology in Oral Squamous Cell Carcinoma.

Authors:  Min Cai; Rukeng Tan; Yunyi Huang; Xuanyi Chen; Qingci Kong; Kaixin Guo; Meng Xu
Journal:  Pathol Oncol Res       Date:  2021-04-16       Impact factor: 3.201

9.  Transcriptome-Guided Drug Repurposing for Aggressive SCCs.

Authors:  Roland Zauner; Monika Wimmer; Sonja Dorfer; Michael Ablinger; Ulrich Koller; Josefina Piñón Hofbauer; Christina Guttmann-Gruber; Johann W Bauer; Verena Wally
Journal:  Int J Mol Sci       Date:  2022-01-17       Impact factor: 5.923

Review 10.  Human Papillomavirus and Survival of Sinonasal Squamous Cell Carcinoma Patients: A Systematic Review and Meta-Analysis.

Authors:  Anish Sharma; Alice L Tang; Vinita Takiar; Trisha M Wise-Draper; Scott M Langevin
Journal:  Cancers (Basel)       Date:  2021-07-22       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.